Clinical Trials Logo

Clinical Trial Summary

Partially assisted mechanical ventilation is ideally titrated to maintain adequate inspiratory muscle activity (i.e. preventing disuse atrophy) while avoiding excessive (i.e. fatiguing) inspiratory loads. The advent of ventilator modes enabling flow and pressure assistance in proportion to patient inspiratory effort (i.e. Proportional Assist Ventilation (PAV), Neurally-Adjusted Ventilator Assist (NAVA)) permit careful titration of ventilatory support to achieve desired levels of patient inspiratory effort. However, data on the acceptable range of values for inspiratory effort and respiratory muscle load-capacity balance during mechanical ventilation are currently very limited. Such data are critical to inform a physiologically sound evidence-based approach to titrating partially-assisted ventilatory support. This study is designed to ascertain a physiologically acceptable range of inspiratory effort in mechanically ventilated patients. The study protocol includes measurements of the respiratory system during spontaneous breathing as well as evaluating the diaphragm in real-time with the use of ultrasonography. The experimental design outlined in the present study is predicated on the assumption that the range of values for inspiratory effort and load-capacity balance observed in patients who are successfully weaned from mechanical ventilation represent the safe and appropriate range of target values.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02838524
Study type Observational
Source St. Michael's Hospital, Toronto
Contact
Status Completed
Phase
Start date September 2016
Completion date March 1, 2018

See also
  Status Clinical Trial Phase
Completed NCT02566525 - CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery N/A
Completed NCT00879931 - Influence of Corticoids on Renal Function in Cardiac Surgery Phase 2
Recruiting NCT05662501 - Pleiades Safety and Feasibility Study N/A
Completed NCT02407873 - Prognostic Impact of Frailty Assessed by Edmondon in Elderly Patient Undergoing Cardiac Surgery N/A
Not yet recruiting NCT01418521 - Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery Phase 4
Completed NCT01748266 - Microcirculation of the Thenar Eminence N/A
Terminated NCT03384875 - CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery N/A